Literature DB >> 17481462

Integrating hepatitis prevention services into a substance use disorder clinic.

Hildi Hagedorn1, Eric Dieperink, Debra Dingmann, Janet Durfee, Samuel B Ho, Carl Isenhart, Nancy Rettmann, Mark Willenbring.   

Abstract

The Healthy Liver Program, established at the Minneapolis Veterans Affairs Medical Center Substance Use Disorder Clinic, provides screening for exposure to hepatitis infections, a group education class, and an individual nursing appointment to review screening results, give vaccinations for hepatitis A and hepatitis B, and make referrals to the hepatitis clinic as appropriate. A patient chart audit was completed 11 months after the establishment of the Healthy Liver Program. The attendance rate for the educational group and individual feedback sessions was 66.9%, with 94.1% of attendees accepting recommended hepatitis A and/or hepatitis B vaccinations. All patients with chronic hepatitis C who attended the Healthy Liver Program received a referral for evaluation in the hepatitis clinic, as compared with only 50% of patients with chronic hepatitis C who were identified before the establishment of the program. The importance of providing comprehensive educational sessions and recommendations for how patients with substance use disorders can access hepatitis screening, vaccination, and treatment resources are stressed.

Entities:  

Mesh:

Year:  2006        PMID: 17481462     DOI: 10.1016/j.jsat.2006.10.004

Source DB:  PubMed          Journal:  J Subst Abuse Treat        ISSN: 0740-5472


  12 in total

1.  What defines high quality care for patients with chronic hepatitis C and why should we care?

Authors:  Samuel B Ho
Journal:  Dig Dis Sci       Date:  2014-02       Impact factor: 3.199

Review 2.  Hepatitis infection in the treatment of opioid dependence and abuse.

Authors:  Thomas F Kresina; Diana Sylvestre; Leonard Seeff; Alain H Litwin; Kenneth Hoffman; Robert Lubran; H Westley Clark
Journal:  Subst Abuse       Date:  2008-04-28

3.  Hepatitis A/B vaccine completion among homeless adults with history of incarceration.

Authors:  Adeline M Nyamathi; Elizabeth Marlow; Catherine Branson; Mary Marfisee; Karabi Nandy
Journal:  J Forensic Nurs       Date:  2012-01-06       Impact factor: 1.175

4.  Engagement in Care of High-Risk Hepatitis C Patients with Interferon-Free Direct-Acting Antiviral Therapies.

Authors:  John B Dever; Julie H Ducom; Ariel Ma; Joseph Nguyen; Lin Liu; Ann Herrin; Erik J Groessl; Samuel B Ho
Journal:  Dig Dis Sci       Date:  2017-04-04       Impact factor: 3.199

5.  The relationship between baseline Organizational Readiness to Change Assessment subscale scores and implementation of hepatitis prevention services in substance use disorders treatment clinics: a case study.

Authors:  Hildi J Hagedorn; Paul W Heideman
Journal:  Implement Sci       Date:  2010-06-14       Impact factor: 7.327

6.  HBV and HCV test uptake and correlates among men who have sex with men in China: a nationwide cross-sectional online survey.

Authors:  Thomas Fitzpatrick; Stephen W Pan; Weiming Tang; Wilson Guo; Joseph D Tucker
Journal:  Sex Transm Infect       Date:  2018-05-19       Impact factor: 3.519

7.  Predicting implementation from organizational readiness for change: a study protocol.

Authors:  Christian D Helfrich; Dean Blevins; Jeffrey L Smith; P Adam Kelly; Timothy P Hogan; Hildi Hagedorn; Patricia M Dubbert; Anne E Sales
Journal:  Implement Sci       Date:  2011-07-22       Impact factor: 7.327

8.  A Patient-Centered Hepatitis B Virus (HBV) Educational Intervention Improves HBV Care Among Underserved Safety-Net Populations.

Authors:  Robert J Wong; Mandana Khalili
Journal:  J Clin Gastroenterol       Date:  2020-08       Impact factor: 3.174

9.  A Training Model for Implementing Hepatitis Prevention Services in Substance Use Disorder Clinics: A Qualitative Evaluation.

Authors:  Hildi J Hagedorn; Nancy Rettmann; Eric Dieperink; Astrid Knott; Bruce E Landon
Journal:  J Gen Intern Med       Date:  2015-08       Impact factor: 5.128

10.  Practical steps to improve chronic hepatitis C treatment in people with opioid use disorder.

Authors:  Carlos Roncero; Pablo Ryan; Richard Littlewood; Juan Macías; Juan Ruiz; Pedro Seijo; Raúl Felipe Palma-Álvarez; Pablo Vega
Journal:  Hepat Med       Date:  2018-12-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.